The main idea here is that uncomplicated acute otitis media in patients without penicillin allergy should be treated with a narrow, reliable antibiotic that covers the usual ear pathogens and reaches good levels in the middle ear. Amoxicillin fits best because of its strong activity against the common culprits—Streptococcus pneumoniae, non-typeable Haemophilus influenzae, and Moraxella catarrhalis—combined with excellent oral bioavailability. When given in a high-dose regimen (about 80–90 mg/kg/day, split into two doses, for about 5–10 days), amoxicillin achieves sufficient concentrations in middle ear fluid to treat organisms that may have reduced susceptibility and to reduce treatment failures. It’s also cost-effective and generally well tolerated, making it a practical first choice. The other options are more appropriate in specific scenarios. Cefdinir can be used if amoxicillin cannot be given, but it’s not the preferred first-line due to broader spectrum and other practical considerations. Azithromycin has higher rates of resistance among the usual otitis media pathogens, reducing its effectiveness as first-line therapy. Clindamycin covers some bacteria but lacks reliable activity against non-typeable H. influenzae and Moraxella and carries a higher risk of Clostridioides difficile infection, so it’s not favored as initial therapy.

Lithium is cleared by the kidneys and its level in the blood is very sensitive to changes in kidney function and sodium balance. It is filtered and then reabsorbed in the proximal tubule along with sodium, so anything that reduces kidney filtration or alters sodium handling can raise lithium levels and increase toxicity risk. NSAIDs or aspirin are particularly important here because they decrease prostaglandin synthesis in the kidney, which lowers renal perfusion and glomerular filtration. With less filtration, lithium reabsorption in the proximal tubule increases, leading to higher serum lithium concentrations and a greater danger of toxicity (tremor, confusion, ataxia, seizures, etc.). That’s why these drugs should be avoided or used with caution in someone taking lithium, and an alternative pain reliever like acetaminophen is often recommended unless a clinician advises otherwise. Maintaining a stable salt intake and adequate hydration helps keep lithium levels steadier, since significant changes in sodium balance can also shift lithium reabsorption. Regular exercise is generally fine, and daily vitamin C isn’t a major concern with lithium. So the reason the best choice is the NSAIDs or aspirin is their direct impact on kidney function and lithium clearance, increasing the risk of toxicity.

Cardiac glycosides produce a strong positive inotropic effect by blocking the Na+/K+ ATPase pump in cardiac muscle cells. This raises intracellular sodium, which reduces the activity of the Na+/Ca2+ exchanger that normally removes calcium from the cell. With less calcium being expelled, intracellular calcium accumulates, increasing calcium availability for the contractile machinery during systole and thereby strengthening each heartbeat. This direct increase in force of contraction is the hallmark effect of digoxin on the heart. The other options aren’t the primary cardiac actions of digoxin. It does not act as a direct vasodilator of peripheral arteries, and increases in urine output or decreases in blood pressure aren’t primary effects of its action on the myocardium.

Buspirone works through a serotonergic mechanism with some dopaminergic activity, which is why this statement is true. It acts mainly as a partial agonist at 5-HT1A receptors (a serotonin receptor) and also interacts with dopamine receptors, giving it a distinct profile from benzodiazepines. This explains why it doesn’t provide the rapid relief seen with benzodiazepines—effects build up over several days to weeks with consistent dosing. It is not a benzodiazepine, and it can be taken with or without food, so there’s no need to avoid eating with it.